Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Amy B. Papaneri"'
Publikováno v:
npj Parkinson's Disease, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Diagnosing Parkinson’s disease (PD) before the clinical onset proves difficult because the hallmark PD symptoms do not manifest until more than 60% of dopamine neurons in the substantia nigra pars compacta have been lost. Here we show that
Externí odkaz:
https://doaj.org/article/144317510e56488fa2d81fe1b1a64459
Autor:
Jingheng, Zhou, Alan, Yeh, Chengbo, Meng, Amy B, Papaneri, Teja, Peddada, Nicholas P, Kobzar, Guohong, Cui
Publikováno v:
Current Protocols. 2
This article describes how to assemble and operate a spectrometer-based fiber photometry system for in vivo simultaneous measurements of multiple fluorescent biosensors in freely moving mice. The first section of the article describes the step-by-ste
Publikováno v:
Neuropharmacology. 226:109397
Autor:
Mitzie Walker, Robert D. Keys, Negin P. Martin, Amy B. Papaneri, Erica Scappini, Shih Heng Chen
Recombinant adeno-associated viruses (AAVs) are robust and versatile tools forin vivogene delivery. Natural and designer capsid variations in AAVs allow for targeted gene delivery to specific cell types. Low immunogenicity and lack of pathogenesis al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582a8ace283377fe8b13186787a69b3e
https://doi.org/10.1101/715029
https://doi.org/10.1101/715029
Autor:
Katie R. Hagen, Amy B. Papaneri, Matthias J. Schnell, David R. Liu, Tiago Abreu-Mota, Reed F. Johnson, Rohan Keshwara, Christoph Wirblich
Marburg virus (MARV) is a filovirus related to Ebola virus (EBOV) associated with human hemorrhagic disease. Outbreaks are sporadic and severe, with a reported case mortality rate of upward of 88%. There is currently no antiviral or vaccine available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::930c643ee751510dbd8ebed00599cda9
https://europepmc.org/articles/PMC6401435/
https://europepmc.org/articles/PMC6401435/
Autor:
Shih Heng Chen, Mitzie Walker, Erica Scappini, Robert D. Keys, Negin P. Martin, Amy B. Papaneri
Publikováno v:
J Virol Methods
Recombinant adeno-associated viruses (rAAVs) are robust and versatile tools for in vivo gene delivery. Natural and designer capsid variations in rAAVs allow for targeted gene delivery to specific cell types. Low immunogenicity and lack of pathogenesi
Autor:
Amy B. Papaneri, Peter B. Jahrling, Jens H. Kuhn, Reed F. Johnson, Laura Bollinger, Jiro Wada
Publikováno v:
Expert Review of Vaccines
The recent emergence of Middle East respiratory syndrome (MERS) highlights the need to engineer new methods for expediting vaccine development against emerging diseases. However, several obstacles prevent pursuit of a licensable MERS vaccine. First,
Autor:
Amy B. Papaneri, John G. Bernbaum, Matthias J. Schnell, Peter B. Jahrling, Joseph E. Blaney, Reed F. Johnson
Publikováno v:
Virus Research
Using a recombinant rabies (RABV) vaccine platform, we have developed several safe and effective vaccines. Most recently, we have developed a RABV-based ebolavirus (EBOV) vaccine that is efficacious in nonhuman primates. One safety feature of this va
Autor:
Jennifer A. Cann, Matthias J. Schnell, Peter B. Jahrling, Amy B. Papaneri, Joseph E. Blaney, Kurt Cooper, Christoph Wirblich
Publikováno v:
Virology
We are developing inactivated and live-attenuated rabies virus (RABV) vaccines expressing Ebola virus (EBOV) glycoprotein for use in humans and endangered wildlife, respectively. Here, we further characterize the pathogenesis of the live-attenuated R
Autor:
Drishya Kurup, Jonathan T. Wang, Donna L. Perry, Matthias J. Schnell, Katie R. Hagen, Jan ter Meulen, Christoph Wirblich, Reed F. Johnson, Peter B. Jahrling, Rohan Keshwara, Amy B. Papaneri, Christine R. Fisher, Kurt Cooper
Publikováno v:
The Journal of infectious diseases. 214(suppl 3)
The 2013-2016 West African Ebola virus (EBOV) disease outbreak was the largest filovirus outbreak to date. Over 28 000 suspected, probable, or confirmed cases have been reported, with a 53% case-fatality rate. The magnitude and international impact o